Portuguese biotech firm seeks to launch Chinese drug to combat Parkinson’s

Portuguese pharmaceutical company Tecnophage intends to launch a supplement in Europe this year with “very promising” results in Parkinson’s disease, based on research from the University of Macau on a fruit used in traditional Chinese medicine. The company’s CEO Miguel Garcia has told Lusa Tecnophage is “in the last steps of toxicity tests of the molecule”, which should be completed “in the first quarter”. As for results so far, they show the supplement “could reduce the loss of memory and control of movement”, symptoms of “neurocognitive degeneration” caused by Parkinson’s disease and Alzheimer’s disease.